Impact Factor Collection
Endocrine-Related Cancer’s 2020 Impact Factor has risen to 5.678, with the five-year measure now standing at 6.169.
This increase in Impact Factor reflects the high-quality research identified by the Editorial Board, their hard work to ensure the upmost quality, and strong leadership. The journal now ranks 30 out of 145 journals in the Endocrinology and Metabolism category, placing it in the top quartile of journals, and 74 out of 242 in the Oncology category.
2020’S TOP CITED RESEARCH:
Peptide receptor radionuclide therapy in gastroenteropancreatic NEN G3: a multicenter cohort study
Esben Andreas Carlsen et al.
Immune checkpoint markers in gastroenteropancreatic neuroendocrine neoplasia
Florian Bösch et al.
Neuroendocrine differentiation of prostate cancer leads to PSMA suppression
Martin K Bakht et al.
2020’S TOP CITED REVIEWS:
French Endocrine Society Guidance on endocrine side effects of immunotherapy
F Castinetti et al.
Overcoming CDK4/6 inhibitor resistance in ER-positive breast cancer
Neil Portman et al.
Medullary thyroid carcinoma beyond surgery: advances, challenges, and perspectivess
Lucieli Ceolin et al.
Role of chemokine receptors in thyroid cancer and immunotherapy
Francesca Coperchini et al.
Oxidative stress in thyroid carcinomas: biological and clinical significance
Rabii Ameziane El Hassani et al.
Clock genes and cancer development in particular in endocrine tissues
Anna Angelousi et al.
Otubain 1: a non-canonical deubiquitinase with an emerging role in cancer
Matthew Saldana et al.
Mechanisms linking the renin-angiotensin system, obesity, and breast cancer
Fahmida Rasha et al.
Epigenetic changes in fibroblasts drive cancer metabolism and differentiation
Rajeev Mishra et al.